Tornier, N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that its Board of Directors has appointed David H. Mowry as President and Chief Executive Officer, effective immediately. Sean D. Carney, Chairman of Tornier, commented, “Dave has demonstrated an intensity and concentration in executing on the key initiatives in his charge since joining Tornier in July 2011 as Chief Operating Officer. That expertise, combined with his extensive industry experience and outstanding leadership qualities, make Dave the right executive to continue to build Tornier’s strong brand and reputation in the extremities market.” David H. Mowry commented, “Tornier’s industry expertise, broad product portfolio, and cadence of delivering innovation position the Company as a recognized global leader in the large and growing extremities markets. We believe the increased focus on execution of our US sales channel alignment, OrthoHelix integration, and delivering through our strong product pipeline will return Tornier to double-digit, constant currency revenue growth on a pro forma basis. I am grateful to the Board of Directors for the opportunity to lead Tornier, and I am excited to work with the talented and dedicated Tornier team.” Mr. Mowry joined Tornier N.V. in July 2011 as Chief Operating Officer. He brings to Tornier 23 years of medical device industry experience in various engineering and management assignments. Prior to Tornier, Mr. Mowry served as Senior Vice President and President of the Neurovascular Division of Covidien plc, and in the same position with ev3 Inc., prior to its acquisition by Covidien. Before joining ev3, Mr. Mowry served as Vice President of Operations and Logistics at the Zimmer Spine division of Zimmer Holdings Inc. Mr. Mowry is a graduate of the United States Military Academy at West Point, New York with a degree in Engineering and Mathematics.